The 3 Tests

Three FDA-cleared tests. One 15-minute screening.

ABI, ANS, and Sudomotor — a complete cardiovascular signal captured in a single non-invasive office visit and reimbursed by Medicare and most private insurers.

The Protocol
ABI
93923
ANS
95921
Sudomotor
95923
Follow-up
99214
What we measure

A complete cardiovascular signal — head to toe.

Most PAD screening looks at one signal in one place. Our protocol captures three — vascular flow, autonomic balance, and small-fiber nerve function — and reads them against each other.

The result is a clinical picture no single test can produce, surfaced in a single 15-minute office visit.

  • Vascular blood flow (ABI)
  • Autonomic nervous system balance
  • Small-fiber neuropathy (sudomotor)
Vascular system diagram with waveform analysis

Full-body vascular and autonomic signal capture across the 3-test protocol.

CPT 95923

Sudomotor

Measures sweat-gland function as an early indicator of small-fiber neuropathy and autonomic dysfunction — often the first sign of diabetic or vascular damage.

  • Detects small-fiber neuropathy 10+ years earlier
  • Non-invasive, no needles, no preparation
  • Strong predictor of cardiovascular events
CPT 95921

Autonomic Nervous System (ANS)

Evaluates heart-rate variability and parasympathetic balance — a validated marker for cardiovascular risk, diabetic autonomic neuropathy, and silent ischemia.

  • Identifies silent cardiac autonomic dysfunction
  • AHA & ADA recognized assessment
  • Guides risk stratification and treatment
CPT 93923

Ankle-Brachial Index (ABI)

The gold-standard non-invasive PAD test. Compares blood pressure at the ankle to the brachial artery to detect arterial blockages in the lower extremities.

  • Direct PAD diagnostic — sensitive and specific
  • Recommended by AHA for at-risk populations
  • Predicts heart attack and stroke risk
CPT 99214

Follow-Up Visit

Detected patients return for a level-4 office visit so the provider can interpret findings, document risk, and place orders — captured under standard E/M billing.

  • Recurring follow-up revenue stream
  • Documents medical necessity for downstream care
  • Drives cardiology, vascular, endocrine referrals
15 Minutes · Non-Invasive

Three pillars of cardiovascular risk. One visit.

PAD doesn't show up alone. The 3-test protocol captures vascular, autonomic, and small-fiber signals simultaneously — giving providers a complete cardiovascular risk picture in a single patient visit.

The Next Step

Ready to bring Pulse4Physicians to your organization?

15 minutes. No commitment. We'll walk you through the program, the billing, and how Pulse4Pulse delivers PAD screening at your practice.